Does the Fetus Limit Antibiotic Treatment in Pregnant Patients with COVID-19?

Does the Fetus Limit Antibiotic Treatment in Pregnant Patients with COVID-19?

During pregnancy, there is a state of immune tolerance that predisposes them to viral infection, causing maternal-fetal vulnerability to the adverse effects of COVID-19. Bacterial coinfections significantly increase the mortality rate for COVID-19. However, it is known that all drugs, including anti...

Full description

Bibliographic Details
Main Authors: Tito Ramírez-Lozada, María Concepción Loranca-García, Claudia Erika Fuentes-Venado, Carmen Rodríguez-Cerdeira, Esther Ocharan-Hernández, Marvin A. Soriano-Ursúa, Eunice D. Farfán-García, Edwin Chávez-Gutiérrez, Xóchitl Ramírez-Magaña, Maura Robledo-Cayetano, Marco A. Loza-Mejía, Ivonne Areli Garcia Santa-Olalla, Oscar Uriel Torres-Paez, Rodolfo Pinto-Almazán, Erick Martínez-Herrera
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Antibiotics
Subjects:
antibiotics
pregnancy
COVID-19
fetus
microbiota
placenta
Online Access:https://www.mdpi.com/2079-6382/11/2/252

Internet

https://www.mdpi.com/2079-6382/11/2/252

Similar Items